These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Laboratory monitoring of therapy with OKT3 and other murine monoclonal antibodies. Colvin RB, Preffer FI. Clin Lab Med; 1991 Sep; 11(3):693-714. PubMed ID: 1934971 [Abstract] [Full Text] [Related]
13. A U.S. clinical study of Orthoclone OKT3 in renal transplantation. Norman DJ, Shield CF, Barry J, Henell K, Funnell MB, Lemon J. Transplant Proc; 1987 Apr; 19(2 Suppl 1):21-7. PubMed ID: 3105136 [No Abstract] [Full Text] [Related]
14. Reversing cardiac transplant rejection with Orthoclone OKT3. Dault LA, Nagy CS, Collins JA. Am J Nurs; 1989 Jul; 89(7):953-5. PubMed ID: 2500020 [No Abstract] [Full Text] [Related]
16. [Orthoclone OKT3 (Muromonab CD3)--the indications for and manner of its use. Side effects and their prevention]. Filev A, Kumanov Kh, Slavov Ch, Tsvetkov M. Khirurgiia (Sofiia); 1989 Jul; 42(6):80-2. PubMed ID: 2517512 [Abstract] [Full Text] [Related]
17. Muromonab-CD3 (Orthoclone OKT3): the first monoclonal antibody approved for therapeutic use. Emmons C, Hunsicker LG. Iowa Med; 1987 Feb; 77(2):78-82. PubMed ID: 3557906 [No Abstract] [Full Text] [Related]
18. Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection. Norman DJ, Shield CF, Henell KR, Kimball J, Barry JM, Bennett WM, Leone M. Transplantation; 1988 Oct; 46(4):523-9. PubMed ID: 3140448 [Abstract] [Full Text] [Related]